Petros Pharmaceuticals aims to expand access to prescription drugs by developing them into over-the-counter treatments. Fady Boctor discusses the company's focus on Rx-to-OTC market growth, particularly in erectile dysfunction therapeutics, with a potential market value of $66.5 billion by 2033.